{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:57:59Z","timestamp":1791356279967,"version":"4.3.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/01.pas.0000213351.49767.0f","type":"journal-article","created":{"date-parts":[[2006,12,19]],"date-time":"2006-12-19T09:02:45Z","timestamp":1166518965000},"page":"121-128","source":"Crossref","is-referenced-by-count":147,"title":["BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays"],"prefix":"10.1097","volume":"31","author":[{"given":"Anita L.","family":"Bane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne C.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Bleiweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saundra S.","family":"Buys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy K.","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanina","family":"Hibshoosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester","family":"Layfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Longacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubie","family":"Senie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Southey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dee W.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice S.","family":"Whittemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene L.","family":"Andrulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances P.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210130","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R2-15-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1005853022804","article-title":"Inherited BRCA2 mutation associated with high grade breast cancer","volume":"47","author":"Agnarsson","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"R3-15-20210130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jnci\/85.3.200","article-title":"Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer [see comments]","volume":"85","author":"Allred","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R4-15-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/humu.10097","article-title":"Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations","volume":"20","author":"Andrulis","year":"2002","journal-title":"Hum Mutat"},{"key":"R5-15-20210130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(05)79248-5","article-title":"Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group","volume":"352","author":"Ansquer","year":"1998","journal-title":"Lancet"},{"key":"R6-15-20210130","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","article-title":"The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study","volume":"83","author":"Armes","year":"1998","journal-title":"Cancer"},{"key":"R7-15-20210130","first-page":"2011","article-title":"Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study","volume":"59","author":"Armes","year":"1999","journal-title":"Cancer Res"},{"key":"R8-15-20210130","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1126\/science.306.5705.2187c","article-title":"Breast cancer risks for BRCA1\/2 carriers","volume":"306","author":"Easton","year":"2004","journal-title":"Science"},{"key":"R9-15-20210130","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/bcr953","article-title":"Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families","volume":"7","author":"Eerola","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R10-15-20210130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"R11-15-20210130","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study [see comments]","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R12-15-20210130","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-03-1061","article-title":"Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type, 2004","volume":"10","author":"Foulkes","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R13-15-20210130","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","article-title":"Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer","volume":"95","author":"Foulkes","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R14-15-20210130","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"R15-15-20210130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0959-8049(97)89007-7","article-title":"Tumour biological features of BRCA1-induced breast and ovarian cancer","volume":"33","author":"Johannsson","year":"1997","journal-title":"Eur J Cancer"},{"key":"R16-15-20210130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","article-title":"Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden","volume":"16","author":"Johannsson","year":"1998","journal-title":"J Clin Oncol"},{"key":"R17-15-20210130","doi-asserted-by":"crossref","first-page":"R375","DOI":"10.1186\/bcr801","article-title":"The breast cancer family registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer","volume":"6","author":"John","year":"2004","journal-title":"Breast Cancer Res"},{"key":"R18-15-20210130","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) breast cancer prevention trial","volume":"286","author":"King","year":"2001","journal-title":"JAMA"},{"key":"R19-15-20210130","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med"},{"key":"R20-15-20210130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R21-15-20210130","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"key":"R22-15-20210130","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","article-title":"Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype","volume":"11","author":"Lakhani","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R23-15-20210130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jnci\/91.3.259","article-title":"Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers","volume":"91","author":"Lee","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R24-15-20210130","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/modpathol.3800491","article-title":"TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays","volume":"18","author":"Liu","year":"2005","journal-title":"Mod Pathol"},{"key":"R25-15-20210130","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0002-9440(10)64434-3","article-title":"Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays","volume":"161","author":"Liu","year":"2002","journal-title":"Am J Pathol"},{"key":"R26-15-20210130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W","article-title":"Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes","volume":"83","author":"Loman","year":"1998","journal-title":"Cancer"},{"key":"R27-15-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/modpathol.3800496","article-title":"Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study","volume":"19","author":"Longacre","year":"2006","journal-title":"Mod Pathol"},{"key":"R28-15-20210130","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0046-8177(98)90427-0","article-title":"Pathobiologic characteristics of hereditary breast cancer","volume":"29","author":"Lynch","year":"1998","journal-title":"Hum Pathol"},{"key":"R29-15-20210130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W","article-title":"Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage","volume":"77","author":"Marcus","year":"1996","journal-title":"Cancer"},{"key":"R30-15-20210130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1005830230664","article-title":"BRCA2 hereditary breast cancer pathophenotype","volume":"44","author":"Marcus","year":"1997","journal-title":"Breast Cancer Res Treat"},{"key":"R31-15-20210130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.10641","article-title":"Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy","volume":"101","author":"Moller","year":"2002","journal-title":"Int J Cancer"},{"key":"R32-15-20210130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1309\/VP4W-5C55-7M09-6TX3","article-title":"Comparison of HER2\/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry","volume":"115","author":"O'Malley","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R33-15-20210130","first-page":"35","article-title":"Prognostic indicators in breast cancer and who needs them","volume":"2","author":"Page","year":"1997","journal-title":"Anat Pathol"},{"key":"R34-15-20210130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-004-1536-0","article-title":"Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers","volume":"90","author":"Palacios","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R35-15-20210130","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/bjs.1800811038","article-title":"Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21","volume":"81","author":"Porter","year":"1994","journal-title":"Br J Surg"},{"key":"R36-15-20210130","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/cncr.10949","article-title":"HER2\/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA-1 mutation status in the OFBCR","volume":"95","author":"Quenneville","year":"2002","journal-title":"Cancer"},{"key":"R37-15-20210130","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","article-title":"BRCA-associated breast cancer in young women","volume":"16","author":"Robson","year":"1998","journal-title":"J Clin Oncol"},{"key":"R38-15-20210130","first-page":"1839","article-title":"BRCA-associated breast cancer: absence of a characteristic immunophenotype","volume":"58","author":"Robson","year":"1998","journal-title":"Cancer Res"},{"key":"R39-15-20210130","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med"},{"key":"R40-15-20210130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"R41-15-20210130","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-15-20210130","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"Sotiriou","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R43-15-20210130","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1128\/MCB.6.5.1729","article-title":"p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity","volume":"6","author":"Stern","year":"1986","journal-title":"Mol Cell Biol"},{"key":"R44-15-20210130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ijc.10666","article-title":"A BRCA1\/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography","volume":"102","author":"Tilanus-Linthorst","year":"2002","journal-title":"Int J Cancer"},{"key":"R45-15-20210130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","article-title":"Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1","volume":"351","author":"Verhoog","year":"1998","journal-title":"Lancet"},{"key":"R46-15-20210130","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","article-title":"Breast and ovarian cancer","volume":"348","author":"Wooster","year":"2003","journal-title":"N Engl J Med"},{"key":"R47-15-20210130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1073\/pnas.92.1.87","article-title":"Screening for mutations by enzyme mismatch cleavage with T4 endonuclease VII","volume":"92","author":"Youil","year":"1995","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-200701000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:19:02Z","timestamp":1618031942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-200701000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pas.0000213351.49767.0f","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}